Bitopertin is an investigational drug.
There have been 13 clinical trials for Bitopertin.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, Protoporphyria, Erythropoietic, and beta-Thalassemia. The leading clinical trial sponsors are Hoffmann-La Roche, Disc Medicine, Inc, and Karolinska Institutet.